Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...

On Dec. 15, Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in women who are past menopause. Addyi works by addressing neurotransmitters like ...

"I am deeply honored to be named to the TIME100 Health list," said Cindy Eckert, Founder and CEO of Sprout Pharmaceuticals. "Every disruptor dreams of the moment that culture reflects that what ...

The FDA expanded its approval of Addyi, a pill to treat low libido in women, to include postmenopausal women up to age 65. The approval will open up new treatment options for older women, but experts ...

Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...

On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved ...

IRVINE, CA – July 5, 2023 – The Ad Firm is thrilled to announce the publication of an abstract by Sprout Pharmaceuticals, showcasing the remarkable effects of Addyi (flibanserin) on low libido among ...

U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by postmenopausal women up to 65 years old.The ...

The MarketWatch News Department was not involved in the creation of this content. Recognition follows Addyi's newly expanded FDA approval to treat both premenopausal and postmenopausal women under age ...

WASHINGTON -- The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to ...